Multiple myeloma, or blood plasma cancer is characterized by increased blood vessel formulation (angiogenesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient’s own stem cells. The data in the table below represent the bone marrow micro-vessel density for patients who had a complete response to the stem cell transplant and at the time the complete response was determined. Patient Before After 1 158 284 2 189 214 3 202 101 4 353 227 5 416 290 6 426 176 7 441 290
Multiple myeloma, or blood plasma cancer is characterized by increased blood vessel formulation (angiogenesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient’s own stem cells. The data in the table below represent the bone marrow micro-vessel density for patients who had a complete response to the stem cell transplant and at the time the complete response was determined.
|
Patient |
Before |
After |
|
1 |
158 |
284 |
|
2 |
189 |
214 |
|
3 |
202 |
101 |
|
4 |
353 |
227 |
|
5 |
416 |
290 |
|
6 |
426 |
176 |
|
7 |
441 |
290 |
Please show work done by hand and/or using Excel formulas, graphing calculator unavailable.
At the 0.05 level of significance, is there evidence that the mean bone marrow micro-vessel density is
higher before the stem cell transplant than after the stem cell transplant?
Trending now
This is a popular solution!
Step by step
Solved in 3 steps with 2 images
